NHC, NDRC Issue Guidelines to Boost China’s Birth Rates with Reproductive Support Measures
The National Health Commission (NHC) and National Development and Reform Commission (NDRC), along with multiple...
Policy / Regulatory
CDE Releases Draft Guidelines for RWE-Backed Drug Registration Applications
The Center for Drug Evaluation (CDE) has released a notification regarding the “Real-World Evidence (RWE)-backed...
China Ramps Up Monitoring of Clinically Shortage Drugs Involving 109 Varieties
The Ministry of Industry and Information Technology (MIIT), National Health Commission (NHC), National Healthcare Security...
Taihu Bay Healthcare Conference Launches Wuxi IP Protection Center
The 2022 Taihu Bay Future Healthcare Conference was held in Wuxi City, Jiangsu province, China,...
NHSA Cracks Down on Price Gouging in Basic Medical Insurance Scheme
The National Healthcare Security Administration (NHSA) has announced the results of a special investigation, revealing...
CDE Issues Q&As on COVID-19 Antiviral Drug Evaluation Criteria
The Center for Drug Evaluation (CDE) has published a list of Q&As regarding the non-clinical...
NHC Issues Notification on Medication Safety Management and Rational Drug Use
The National Healthcare Commission (NHC) has released a notification focusing on medication safety management and...
NHC Designates National Mental Illness Medical Centers in Beijing and Shanghai
The National Healthcare Commission (NHC) announced the establishment of national mental illness medical centers, designating...
Shenzhen Unveils Measures to Boost Biomedical and Medical Device Industries
Shenzhen’s municipal Development and Reform Commission has released a series of measures to promote the...
Sun Pharma’s Bicalutamide Supply Suspended in Multiple Chinese Regions
India-based Sun Pharma has suspended the supply of its bicalutamide to Beijing, Tianjin, Jilin, Shanghai,...
CDE Releases 61st Batch of Generic Reference Preparations, 34 New Specs Added
The Center for Drug Evaluation (CDE) has released the 61st batch of chemical generic reference...
Chinese Pharmacists Association Releases Draft VBP Drug Management Guidelines for Public Feedback
The Chinese Pharmacists Association (CPA) has released the “National Volume-based Procurement (VBP) Drug Management Expert...
NMPA Releases 56th Batch of GQCE Reference Drugs, Including 14 Injectables
The National Medical Products Administration (NMPA) has released the 56th batch of reference drugs for...
NHSA Issues New Medical Service Pricing Policy to Enhance Public Welfare and Innovation
The National Healthcare Security Administration (NHSA) has released a new notification on medical service pricing...
VBP Round 7 Drug Procurement Contract Awards Top Winners Revealed
China’s 7th national Volume-Based Procurement (VBP) round concluded with winning bids for 60 drug products...
China’s 2021 Healthcare Report Shows Rising Life Expectancy, Increased Medical Spending
China’s National Health Commission (NHC) released the “Healthcare Statistical Communique 2021,” revealing increased healthcare spending,...
NMPA Reclassifies Glucosamine Sulfate to OTC, Mandates Label Revisions
China’s National Medical Products Administration (NMPA) announced that potassium glucosamine sulfate has been reclassified from...
China’s JPO Launches VBP Round for Orthopedic Spine Consumables
China’s Joint Procurement Office (JPO) announced plans on July 11 to conduct a volume-based procurement...
China’s 7th VBP Round Yields 65.5% Drug Price Cuts, Foreign Firms Secure Bids
China’s 7th national volume-based procurement (VBP) round concluded with winning bids averaging a 65.5% price...
NMPA Issues New Vaccine Manufacturing and Distribution Rules
China’s National Medical Products Administration (NMPA) has released the “Vaccine Manufacturing and Distribution Management Measures,”...